DARTMOUTH Nova ScotiaBUSINESS WIREIMV Inc Nasdaq IMV TSX IMV a clinicalstage biopharmaceutical company the Company or IMV today announced that it is advancing the clinical development of a DPXbased vaccine candidate against COVID19 Vaccin 9189 charsDARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company (the “Company” or “IMV”), today announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Va…IMV Inc Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID19